Circadian and Immunity Cycle Talk in Cancer Destination: From Biological Aspects to In Silico Analysis.
cancer immunity cycle
circadian cycle
computational biology
immunotherapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
20 Mar 2022
20 Mar 2022
Historique:
received:
31
01
2022
revised:
16
03
2022
accepted:
17
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Cancer is the leading cause of death and a major problem to increasing life expectancy worldwide. In recent years, various approaches such as surgery, chemotherapy, radiation, targeted therapies, and the newest pillar, immunotherapy, have been developed to treat cancer. Among key factors impacting the effectiveness of treatment, the administration of drugs based on the circadian rhythm in a person and within individuals can significantly elevate drug efficacy, reduce adverse effects, and prevent drug resistance. Circadian clocks also affect various physiological processes such as the sleep cycle, body temperature cycle, digestive and cardiovascular processes, and endocrine and immune systems. In recent years, to achieve precision patterns for drug administration using computational methods, the interaction of the effects of drugs and their cellular pathways has been considered more seriously. Integrated data-derived pathological images and genomics, transcriptomics, and proteomics analyses have provided an understanding of the molecular basis of cancer and dramatically revealed interactions between circadian and immunity cycles. Here, we describe crosstalk between the circadian cycle signaling pathway and immunity cycle in cancer and discuss how tumor microenvironment affects the influence on treatment process based on individuals' genetic differences. Moreover, we highlight recent advances in computational modeling that pave the way for personalized immune chronotherapy.
Identifiants
pubmed: 35326729
pii: cancers14061578
doi: 10.3390/cancers14061578
pmc: PMC8945968
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : CIHR
ID : 51771-10107
Pays : Canada
Références
Cancer Gene Ther. 2021 Feb;28(1-2):5-17
pubmed: 32457487
Nat Commun. 2021 Jan 15;12(1):401
pubmed: 33452241
Aging (Albany NY). 2019 Dec 23;11(24):11814-11828
pubmed: 31881010
Nat Commun. 2021 Sep 1;12(1):5217
pubmed: 34471116
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12662-7
pubmed: 22778400
Front Oncol. 2018 Jun 12;8:185
pubmed: 29946530
J Med Chem. 2018 Jul 26;61(14):5794-5804
pubmed: 29412659
Br J Cancer. 2019 Jan;120(1):45-53
pubmed: 30413828
Mol Syst Biol. 2011 Jun 07;7:496
pubmed: 21654673
Front Genet. 2019 Dec 11;10:1210
pubmed: 31921283
Cancers (Basel). 2016 Oct 21;8(10):
pubmed: 27775650
Commun Biol. 2021 Jul 15;4(1):877
pubmed: 34267327
PeerJ. 2018 Jan 31;6:e4327
pubmed: 29404219
Genes Dev. 2018 Nov 1;32(21-22):1367-1379
pubmed: 30366905
Science. 2012 Aug 17;337(6096):839-42
pubmed: 22859819
Front Cell Dev Biol. 2020 Nov 24;8:616434
pubmed: 33330516
Front Immunol. 2020 Mar 12;11:348
pubmed: 32226427
J Circadian Rhythms. 2006 Feb 16;4:2
pubmed: 16480518
Trends Cell Biol. 2021 Nov;31(11):940-950
pubmed: 34272133
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13516-13521
pubmed: 27834218
Science. 2001 Jul 20;293(5529):510-4
pubmed: 11441146
Immunol Res. 2017 Oct;65(5):987-994
pubmed: 28845509
Curr Pharm Des. 2016;22(46):6935-6945
pubmed: 27669965
Mol Cell Biol. 2009 Jul;29(14):3853-66
pubmed: 19414593
Cancers (Basel). 2020 Jun 29;12(7):
pubmed: 32610705
Front Immunol. 2019 Oct 24;10:2451
pubmed: 31708917
Lancet Oncol. 2021 Dec;22(12):1648-1650
pubmed: 34780710
Sci Rep. 2018 Oct 30;8(1):16023
pubmed: 30375470
Nat Biotechnol. 2004 Oct;22(10):1253-9
pubmed: 15470465
Cell Cycle. 2012 Sep 15;11(18):3481-91
pubmed: 22918252
Trends Immunol. 2019 Jun;40(6):524-537
pubmed: 31109762
Immunity. 2018 Dec 18;49(6):1175-1190.e7
pubmed: 30527911
Endocr Relat Cancer. 2021 Feb;28(2):R55-R66
pubmed: 33300498
BMC Cancer. 2015 Feb 18;15:69
pubmed: 25885822
Trends Endocrinol Metab. 2012 Jul;23(7):319-25
pubmed: 22520961
Front Immunol. 2021 Jul 21;12:690112
pubmed: 34367148
Nat Commun. 2020 Jul 30;11(1):3801
pubmed: 32732879
Nat Commun. 2020 Nov 17;11(1):5848
pubmed: 33203866
Genes Cells. 2018 Apr;23(4):285-293
pubmed: 29508494
Ann Oncol. 2012 Dec;23(12):3110-3116
pubmed: 22745214
Cancer Discov. 2020 Mar;10(3):371-381
pubmed: 31919052
J Hematol Oncol. 2019 Sep 5;12(1):92
pubmed: 31488176
J Biol Chem. 2013 Sep 13;288(37):26505-11
pubmed: 23861436
Front Oncol. 2021 Jan 14;10:605680
pubmed: 33520715
J Biol Phys. 2016 Jan;42(1):107-32
pubmed: 26293211
Nat Rev Mol Cell Biol. 2020 Feb;21(2):67-84
pubmed: 31768006
Bioinformatics. 2021 Sep 13;:
pubmed: 34515762
Trends Cancer. 2019 Aug;5(8):475-494
pubmed: 31421905
Lancet Oncol. 2021 Dec;22(12):1777-1786
pubmed: 34780711
Am J Ther. 2021 Jan-Feb 01;28(1):e111-e117
pubmed: 31033488
Br J Nutr. 2016 Aug;116(3):434-42
pubmed: 27221157
Prog Mol Biol Transl Sci. 2013;119:221-82
pubmed: 23899600
J Immunol Res. 2014;2014:614529
pubmed: 24809063
Nat Struct Mol Biol. 2007 Dec;14(12):1207-13
pubmed: 18037887
Front Cell Dev Biol. 2020 Jun 03;8:402
pubmed: 32582698
J Cell Physiol. 2019 Aug;234(10):16824-16837
pubmed: 30784085
Cell Syst. 2018 Mar 28;6(3):314-328.e2
pubmed: 29525205
PLoS One. 2018 Jun 25;13(6):e0199777
pubmed: 29940038
Front Physiol. 2019 Jun 25;10:682
pubmed: 31293431
Transfus Med Hemother. 2020 Dec;47(6):429-431
pubmed: 33442337
Front Immunol. 2019 Jul 19;10:1719
pubmed: 31379886
Front Endocrinol (Lausanne). 2018 May 04;9:219
pubmed: 29780357
Curr Top Med Chem. 2018;18(12):965-974
pubmed: 29600766
Nat Rev Drug Discov. 2021 Apr;20(4):287-307
pubmed: 33589815
PLoS One. 2011;6(12):e29801
pubmed: 22216357
Cancers (Basel). 2021 Nov 24;13(23):
pubmed: 34885023
Cell. 2015 Mar 26;161(1):84-92
pubmed: 25815987
Nat Commun. 2020 Sep 11;11(1):4575
pubmed: 32917868
Trends Endocrinol Metab. 2015 Aug;26(8):430-7
pubmed: 26113283
Nat Cell Biol. 2020 Jan;22(1):1-3
pubmed: 31907412
Biomolecules. 2021 May 11;11(5):
pubmed: 34064641
Cytokine. 2020 Apr;128:154984
pubmed: 31972343
FEBS Lett. 2010 Jun 18;584(12):2618-25
pubmed: 20227409
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Curr Oncol. 2020 Apr;27(Suppl 2):S87-S97
pubmed: 32368178
Expert Rev Clin Pharmacol. 2013 Jul;6(4):387-401
pubmed: 23927667
Cell Rep. 2018 Jul 10;24(2):366-378
pubmed: 29996098
Sci Rep. 2018 Feb 28;8(1):3782
pubmed: 29491349
Bioinformatics. 2021 Nov 02;:
pubmed: 34726689
Osteoarthritis Cartilage. 2015 Nov;23(11):1981-8
pubmed: 26521744
SAGE Open Med. 2021 Aug 12;9:20503121211034366
pubmed: 34408877
Front Cell Neurosci. 2017 Apr 03;11:91
pubmed: 28420965
DNA Repair (Amst). 2020 Dec;96:102993
pubmed: 33038659
Cell Mol Gastroenterol Hepatol. 2021;12(2):783-784
pubmed: 33939993
Immunity. 2017 Jan 17;46(1):120-132
pubmed: 28087238
Biosci Biotechnol Biochem. 2016 Jun;80(6):1131-40
pubmed: 27022680
Cancer Res. 2019 Aug 1;79(15):3806-3814
pubmed: 31300477
J Physiol Sci. 2018 May;68(3):207-219
pubmed: 29460036
Cancers (Basel). 2019 Oct 22;11(10):
pubmed: 31652660
Nature. 2021 Oct;598(7880):353-358
pubmed: 34588695
Curr Opin Immunol. 2017 Apr;45:43-51
pubmed: 28192720
PLoS Biol. 2017 Dec 7;15(12):e2002940
pubmed: 29216180
Gene Ther. 2007 Feb;14(4):366-75
pubmed: 17036057
Oncogene. 2014 May 15;33(20):2639-54
pubmed: 23752178
Nat Rev Cancer. 2021 Jun;21(6):345-359
pubmed: 33837297
Front Oncol. 2020 Feb 25;10:188
pubmed: 32161718
Nat Mach Intell. 2019 Dec;1(12):568-577
pubmed: 32368721
Comput Struct Biotechnol J. 2021 Sep 02;19:5170-5183
pubmed: 34630937
Cancer Res. 2016 Dec 1;76(23):6774-6777
pubmed: 27864348
Cancer Res. 2013 Dec 15;73(24):7176-88
pubmed: 24154875
BMC Bioinformatics. 2021 May 11;22(1):240
pubmed: 33975535
Am J Cancer Res. 2020 Mar 01;10(3):727-742
pubmed: 32266087
Genome Med. 2019 Dec 17;11(1):82
pubmed: 31847894
FASEB J. 2019 Jun;33(6):7479-7489
pubmed: 30888851
Biology (Basel). 2017 Feb 04;6(1):
pubmed: 28165421
Sci Rep. 2018 Jun 11;8(1):8857
pubmed: 29891981
Mol Metab. 2016 Jan 14;5(3):133-152
pubmed: 26977390
Int J Mol Sci. 2021 Jul 05;22(13):
pubmed: 34281293
Cell Commun Signal. 2020 Apr 7;18(1):59
pubmed: 32264958
Cancers (Basel). 2021 Apr 18;13(8):
pubmed: 33919517
Drug Dev Res. 2020 Sep;81(6):650-670
pubmed: 32314424
Science. 2013 Nov 8;342(6159):727-30
pubmed: 24202171
Cancer Biol Ther. 2020 Apr 2;21(4):344-353
pubmed: 31931676
Nat Commun. 2020 Oct 2;11(1):4946
pubmed: 33009409
Mol Cells. 2016 Jan;39(1):6-19
pubmed: 26810072
Front Endocrinol (Lausanne). 2016 May 02;7:37
pubmed: 27199894
Neuron. 2019 Nov 20;104(4):724-735.e6
pubmed: 31522764
Clin Epigenetics. 2019 May 15;11(1):79
pubmed: 31092281
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
Nat Prod Rep. 2021 Apr 28;38(4):757-781
pubmed: 33118578
Future Med Chem. 2011 Apr;3(5):623-38
pubmed: 21526899
J Biol Chem. 2014 Nov 14;289(46):32064-32072
pubmed: 25271155
Funct Integr Genomics. 2021 Jan;21(1):1-16
pubmed: 33111200
Comput Math Methods Med. 2021 Oct 29;2021:8238833
pubmed: 34745328
Biochem Biophys Res Commun. 2014 Aug 29;451(3):408-14
pubmed: 25109806
Cell. 2016 Jun 16;165(7):1644-1657
pubmed: 27238018
Pharmacogenomics J. 2018 Jan;18(1):56-63
pubmed: 27958379
J Toxicol. 2015;2015:392360
pubmed: 26347774
PLoS Comput Biol. 2012 May;8(5):e1002516
pubmed: 22693436
Front Oncol. 2018 Mar 28;8:86
pubmed: 29644214
Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):27971-27979
pubmed: 33106415
Proc Natl Acad Sci U S A. 2017 May 16;114(20):5312-5317
pubmed: 28439010
Oncotarget. 2016 May 10;7(19):27350-62
pubmed: 27036047
Biomed Pharmacother. 2003 Oct;57 Suppl 1:92s-95s
pubmed: 14572683
Commun Biol. 2018 Nov 22;1:204
pubmed: 30480104
Ann Nutr Metab. 2019;74(4):322-330
pubmed: 31013492
J Immunol. 2015 Dec 1;195(11):5117-22
pubmed: 26589749
Biochem Biophys Res Commun. 2020 Jul 5;527(4):1000-1007
pubmed: 32439175
Sci Rep. 2019 Jun 20;9(1):8909
pubmed: 31222133
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2457-65
pubmed: 22895791
Trends Cancer. 2020 Jul;6(7):605-618
pubmed: 32610070
Biochem Biophys Res Commun. 2017 Aug 19;490(2):290-295
pubmed: 28619514
J Hematol Oncol. 2020 Aug 3;13(1):107
pubmed: 32746880
iScience. 2020 Jun 26;23(6):101229
pubmed: 32554190
Front Immunol. 2018 Dec 20;9:3059
pubmed: 30619378
Int J Urol. 2020 Jun;27(6):518-524
pubmed: 32223039
Am J Pathol. 2015 Dec;185(12):3152-63
pubmed: 26458764
Front Neurosci. 2021 Apr 29;15:657081
pubmed: 33994930
Front Immunol. 2019 Apr 12;10:774
pubmed: 31031765
J Exp Clin Cancer Res. 2021 Apr 1;40(1):119
pubmed: 33794967
Front Immunol. 2019 Sep 24;10:2278
pubmed: 31616440